Genes and pathways underlying regional and cell type changes in Alzheimer's disease.

PubWeight™: 1.12‹?› | Rank: Top 10%

🔗 View Article (PMC 3706780)

Published in Genome Med on May 25, 2013

Authors

Jeremy A Miller1, Randall L Woltjer2, Jeff M Goodenbour3, Steve Horvath4, Daniel H Geschwind5

Author Affiliations

1: Interdepartmental Program for Neuroscience and Human Genetics Department, UCLA, 2309 Gonda Bldg, 695 Charles E Young Dr. South, Los Angeles, CA 90095-1761, USA.
2: Department of Pathology, Oregon Health & Science University, Department of Pathology L113, Portland, OR 97239, USA.
3: Human Genetics Department, UCLA, 2309 Gonda Bldg, 695 Charles E Young Dr. South, Los Angeles, CA 90095-1761, USA.
4: Human Genetics Department and Biostatistics Department, UCLA, 4357A Gonda Bldg, 695 Charles E Young Dr. South, Los Angeles, CA 90095-1761, USA.
5: Human Genetics Department and Neurology Department, UCLA, 2309 Gonda Bldg, 695 Charles E Young Dr. South, Los Angeles, CA 90095-1761, USA.

Articles citing this

Tau overexpression impacts a neuroinflammation gene expression network perturbed in Alzheimer's disease. PLoS One (2014) 1.46

Beyond modules and hubs: the potential of gene coexpression networks for investigating molecular mechanisms of complex brain disorders. Genes Brain Behav (2013) 1.25

Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders. Nat Rev Genet (2015) 1.14

Induction of a common microglia gene expression signature by aging and neurodegenerative conditions: a co-expression meta-analysis. Acta Neuropathol Commun (2015) 0.97

PPAR agonists regulate brain gene expression: relationship to their effects on ethanol consumption. Neuropharmacology (2014) 0.95

Analytical tools and current challenges in the modern era of neuroepigenomics. Nat Neurosci (2014) 0.94

Integrated multi-cohort transcriptional meta-analysis of neurodegenerative diseases. Acta Neuropathol Commun (2014) 0.93

Circuit-wide Transcriptional Profiling Reveals Brain Region-Specific Gene Networks Regulating Depression Susceptibility. Neuron (2016) 0.93

Neuroinflammation in Alzheimer's disease: from pathogenesis to a therapeutic target. J Clin Immunol (2014) 0.93

Building an RNA Sequencing Transcriptome of the Central Nervous System. Neuroscientist (2015) 0.85

Microglial Malfunction: The Third Rail in the Development of Alzheimer's Disease. Trends Neurosci (2015) 0.85

Atypical Rho GTPases of the RhoBTB Subfamily: Roles in Vesicle Trafficking and Tumorigenesis. Cells (2016) 0.83

Identifying robust communities and multi-community nodes by combining top-down and bottom-up approaches to clustering. Sci Rep (2015) 0.82

A protein homeostasis signature in healthy brains recapitulates tissue vulnerability to Alzheimer's disease. Sci Adv (2016) 0.80

Genetic variants in Alzheimer disease - molecular and brain network approaches. Nat Rev Neurol (2016) 0.80

A new model to study neurodegeneration in ataxia oculomotor apraxia type 2. Hum Mol Genet (2015) 0.79

Current advances in systems and integrative biology. Comput Struct Biotechnol J (2014) 0.79

Age and Alzheimer's disease gene expression profiles reversed by the glutamate modulator riluzole. Mol Psychiatry (2016) 0.78

Genome-wide DNA methylation profiling in the superior temporal gyrus reveals epigenetic signatures associated with Alzheimer's disease. Genome Med (2016) 0.78

A transcriptional signature of Alzheimer's disease is associated with a metastable subproteome at risk for aggregation. Proc Natl Acad Sci U S A (2016) 0.77

NeuroTransDB: highly curated and structured transcriptomic metadata for neurodegenerative diseases. Database (Oxford) (2015) 0.77

Regulation of Pyruvate Dehydrogenase Kinase 4 in the Heart Through Degradation by the Lon Protease in Response to Mitochondrial Substrate Availability. J Biol Chem (2016) 0.76

Rubidium and potassium levels are altered in Alzheimer's disease brain and blood but not in cerebrospinal fluid. Acta Neuropathol Commun (2016) 0.75

Integrated analysis of genetic, behavioral, and biochemical data implicates neural stem cell-induced changes in immunity, neurotransmission and mitochondrial function in Dementia with Lewy Body mice. Acta Neuropathol Commun (2017) 0.75

An additional k-means clustering step improves the biological features of WGCNA gene co-expression networks. BMC Syst Biol (2017) 0.75

Tetraspanin 6: a pivotal protein of the multiple vesicular body determining exosome release and lysosomal degradation of amyloid precursor protein fragments. Mol Neurodegener (2017) 0.75

A shortcut for multiple testing on the directed acyclic graph of gene ontology. BMC Bioinformatics (2014) 0.75

The human-specific CASP4 gene product contributes to Alzheimer-related synaptic and behavioural deficits. Hum Mol Genet (2016) 0.75

Integrated analysis of differential gene expression profiles in hippocampi to identify candidate genes involved in Alzheimer's disease. Mol Med Rep (2015) 0.75

A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer's Disease. Cell Syst (2016) 0.75

Connectivity, not region-intrinsic properties, predicts regional vulnerability to progressive tau pathology in mouse models of disease. Acta Neuropathol Commun (2017) 0.75

Dissecting the Molecular Mechanisms of Neurodegenerative Diseases through Network Biology. Front Aging Neurosci (2017) 0.75

Articles cited by this

Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res (2002) 76.95

Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (1991) 49.03

Identifying biological themes within lists of genes with EASE. Genome Biol (2003) 31.72

Genome-wide atlas of gene expression in the adult mouse brain. Nature (2006) 28.02

A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol (2005) 17.23

A Bayesian framework for the analysis of microarray expression data: regularized t -test and statistical inferences of gene changes. Bioinformatics (2001) 16.47

Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature (2006) 15.69

Gene regulation and DNA damage in the ageing human brain. Nature (2004) 9.01

Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease. Neurobiol Aging (2004) 7.83

Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R. Bioinformatics (2007) 7.72

An anatomically comprehensive atlas of the adult human brain transcriptome. Nature (2012) 7.46

Functional organization of the transcriptome in human brain. Nat Neurosci (2008) 7.02

Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease. Nature (2008) 6.89

Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med (2007) 6.80

Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proc Natl Acad Sci U S A (2006) 6.33

Microglia in neurodegenerative disease. Nat Rev Neurol (2010) 5.83

Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci U S A (2004) 5.65

The genetics of Alzheimer disease: back to the future. Neuron (2010) 4.91

Geometric interpretation of gene coexpression network analysis. PLoS Comput Biol (2008) 4.57

Microglia as mediators of inflammatory and degenerative diseases. Annu Rev Neurosci (1999) 3.90

Inflammatory proteins in plasma and the risk of dementia: the rotterdam study. Arch Neurol (2004) 3.38

Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J Neurosci Res (2002) 3.15

Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor. Neuron (1996) 3.14

A systems level analysis of transcriptional changes in Alzheimer's disease and normal aging. J Neurosci (2008) 2.97

VisANT: an online visualization and analysis tool for biological interaction data. BMC Bioinformatics (2004) 2.88

Divergence of human and mouse brain transcriptome highlights Alzheimer disease pathways. Proc Natl Acad Sci U S A (2010) 2.85

Defining a molecular atlas of the hippocampus using DNA microarrays and high-throughput in situ hybridization. J Neurosci (2004) 2.80

A gene expression profile of Alzheimer's disease. DNA Cell Biol (2001) 2.16

Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set. Physiol Genomics (2008) 2.11

Strategies for aggregating gene expression data: the collapseRows R function. BMC Bioinformatics (2011) 1.96

Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease. Brain (2009) 1.84

Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis. Acta Neuropathol (1996) 1.83

Astroglia in dementia and Alzheimer's disease. Cell Death Differ (2008) 1.83

Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons. Ann Neurol (2000) 1.80

Selectively reduced expression of synaptic plasticity-related genes in amyloid precursor protein + presenilin-1 transgenic mice. J Neurosci (2003) 1.76

An immune response network associated with blood lipid levels. PLoS Genet (2010) 1.74

The organization of the transcriptional network in specific neuronal classes. Mol Syst Biol (2009) 1.74

Microglial activation and amyloid deposition in mild cognitive impairment: a PET study. Neurology (2009) 1.70

Aging of the brain, entropy, and Alzheimer disease. Neurology (2006) 1.68

Neuroinflammation - an early event in both the history and pathogenesis of Alzheimer's disease. Neurodegener Dis (2010) 1.66

LINGO1 and LINGO2 variants are associated with essential tremor and Parkinson disease. Neurogenetics (2010) 1.37

Immune reactive cells in senile plaques and cognitive decline in Alzheimer's disease. Neurobiol Aging (2002) 1.36

Analysis of alternative splicing associated with aging and neurodegeneration in the human brain. Genome Res (2011) 1.35

Alzheimer's disease: mRNA expression profiles of multiple patients show alterations of genes involved with calcium signaling. Neurobiol Dis (2005) 1.26

Gene expression correlates of neurofibrillary tangles in Alzheimer's disease. Neurobiol Aging (2005) 1.24

A genomic screen for modifiers of tauopathy identifies puromycin-sensitive aminopeptidase as an inhibitor of tau-induced neurodegeneration. Neuron (2006) 1.23

The microglial networks of the brain and their role in neuronal network plasticity after lesion. Brain Res Rev (2007) 1.19

The role of ATP-binding cassette transporter A1 in Alzheimer's disease and neurodegeneration. Biochim Biophys Acta (2010) 1.17

Single-cell gene expression analysis: implications for neurodegenerative and neuropsychiatric disorders. Neurochem Res (2004) 1.16

Gene expression profiles in microdissected neurons from human hippocampal subregions. Brain Res Mol Brain Res (2004) 1.04

Expression analysis of mRNA in formalin-fixed, paraffin-embedded archival tissues by mRNA in situ hybridization. Methods (2006) 1.02

Up-regulation of calcineurin Abeta mRNA in the Alzheimer's disease brain: assessment by cDNA microarray. Biochem Biophys Res Commun (2001) 1.01

Tgf-Beta pathway as a potential target in neurodegeneration and Alzheimer's. Curr Alzheimer Res (2006) 0.99

An update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer's disease. Expert Opin Investig Drugs (2009) 0.98

Altered expression of a-type but not b-type synapsin isoform in the brain of patients at high risk for Alzheimer's disease assessed by DNA microarray technique. Neurosci Lett (2001) 0.98

Microglial cell activation in aging and Alzheimer disease: partial linkage with neurofibrillary tangle burden in the hippocampus. J Neuropathol Exp Neurol (1997) 0.96

Astrocytic calcium/zinc binding protein S100A6 over expression in Alzheimer's disease and in PS1/APP transgenic mice models. Biochim Biophys Acta (2004) 0.92

Regional distribution of cortical microglia parallels that of neurofibrillary tangles in Alzheimer's disease. Neurosci Lett (2000) 0.90

Tau phosphorylation in Alzheimer's disease: potential involvement of an APP-MAP kinase complex. Neuromolecular Med (2004) 0.89

Neuroinflammation in Alzheimer's disease: protector or promoter? Bratisl Lek Listy (2006) 0.89

The functional genome of CA1 and CA3 neurons under native conditions and in response to ischemia. BMC Genomics (2007) 0.87

Increased expression of cholesterol transporter ABCA1 is highly correlated with severity of dementia in AD hippocampus. Brain Res (2010) 0.86

Increased density of metallothionein I/II-immunopositive cortical glial cells in the early stages of Alzheimer's disease. Neurobiol Dis (1998) 0.82

Molecular signatures of neurodegeneration in the cortex of PS1/PS2 double knockout mice. Mol Neurodegener (2008) 0.82

RNA expression analysis on formalin-fixed paraffin-embedded tissues in TMA format by RNA in situ hybridization. Methods Mol Biol (2010) 0.81

Bidirectional regulation of Munc13-3 protein expression by age and dark rearing during the critical period in mouse visual cortex. Neuroscience (2007) 0.79